Patient-Derived Antibody Appears to Selectively Target Tumor Cells, Spur Immune Attack



The CFH antibodies killed tumor cells in cell lines of several cancer types and slowed tumor growth in mouse models of brain and lung cancer, without evidence of side effects.



Source link

Comments are closed.